Conference Coverage

Spray-dried plasma inches toward clinical trials

Publish date: February 2, 2018

 

REPORTING FROM AABB 17

SOURCES: Bercovitz R et al. AABB 17 Abstract C20-A02B; Meledeo M et al. AABB 17 Abstract C21-A02B.

Pages

Recommended Reading

Red cell age: No impact on mortality after transfusion
MDedge Hematology and Oncology
Lung injury risk higher with apheresis blood products
MDedge Hematology and Oncology
Restrictive transfusion strategy safe in cardiac surgery
MDedge Hematology and Oncology
Universal paternal Rh screening is cost effective in IVF
MDedge Hematology and Oncology
Panel votes against universal blood donor screens for Zika virus
MDedge Hematology and Oncology
ASCO platelet transfusion guidelines updated
MDedge Hematology and Oncology
Three-month response to CAR T-cells looks durable in DLBCL
MDedge Hematology and Oncology
Denmark reinstates ID NAT screening for blood donations
MDedge Hematology and Oncology
Zika virus testing shows low incidence in donor blood outside of high-infection areas
MDedge Hematology and Oncology
Zika RNA persists in blood components after clearance from plasma
MDedge Hematology and Oncology